Salmon proteoglycan suppresses progression of mouse experimental autoimmune encephalomyelitis via regulation of Th17 and Foxp3+ regulatory T cells

Life Sciences

Volumn 91, Issue 25-26, 2012, Pages 1263-1269

  Sashinami, Hiroshi ^a   Asano, Krisana ^a   Yoshimura, Sayuri ^a   Mori, Fumiaki ^a   Wakabayashi, Koichi ^a   Nakane, Akio ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Encephalomyelitis; Proteoglycan; Regulatory T cells; Th17

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 21 RECEPTOR; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 6 RECEPTOR; PROTEOGLYCAN; TRANSCRIPTION FACTOR FOXP3;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; DISEASE COURSE; EX VIVO STUDY; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SALMON; TH17 CELL; UPREGULATION;

ADMINISTRATION, ORAL; ANIMALS; CARTILAGE; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; LYMPH NODES; MICE; MICE, INBRED C57BL; PROTEOGLYCANS; REAL-TIME POLYMERASE CHAIN REACTION; SALMON; SEVERITY OF ILLNESS INDEX; SPINAL CORD; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

MUS;

EID: 84870296040     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.09.022     Document Type: Article

References (40)

1. S. Aggarwal, N. Ghilardi, M.H. Xie, F.J. de Sauvage, and A.L. Gurney Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 J Biol Chem 278 2003 1910 1914
2. M. Batten, J. Li, S. Yi, N.M. Kljavin, D.M. Danilenko, and S. Lucas Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells Nat Immunol 7 2006 929 936
3. C.L. Bennett, J. Christie, F. Ramsdell, M.E. Brunkow, P.J. Ferguson, and L. Whitesell The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 Nat Genet 27 2001 20 21
4. K. Berer, M. Mues, M. Koutrolos, Z.A. Rasbi, M. Boziki, and C. Johner Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination Nature 479 2011 538 541
5. A.M. Brown, and D.E. McFarlin Relapsing experimental allergic encephalomyelitis in the SJL/J mouse Lab Invest 45 1981 278 284
6. K.E. Brown, K. Leong, C.H. Huang, R. Dalal, G.D. Green, and H.B. Haimes Gelatin/chondroitin 6-sulfate microspheres for the delivery of therapeutic proteins to the joint Arthritis Rheum 41 1998 2185 2195
7. C.T. Brown, A.G. Davis-Richardson, A. Giongo, K.A. Gano, D.B. Crabb, and N. Mukherjee Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes PLoS One 6 2011 e25792
8. J.A. Buckwalter, and L.C. Rosenberg Electron microscopic studies of cartilage proteoglycans. Direct evidence for the variable length of the chondroitin sulfate-rich region of proteoglycan subunit core protein J Biol Chem 257 1982 9830 9839
9. G.M. Campo, A. Avenoso, S. Campo, A.M. Ferlazzo, D. Altavilla, and A. Calatroni Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats Arthritis Res Ther 5 2003 R122 R131
10. J.M. Coquet, S. Chakravarti, M.J. Smyth, and D.I. Godfrey Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis J Immunol 180 2008 7097 7101
11. D.J. Cua, J. Sherlock, Y. Chen, C.A. Murphy, B. Joyce, and B. Seymour Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain Nature 421 2003 744 748
12. E.H. Danen, and K.M. Yamada Fibronectin, integrins, and growth control J Cell Physiol 189 2001 1 13
13. A. Elhofy, K.J. Kennedy, B.T. Fife, and W.J. Karpus Regulation of experimental autoimmune encephalomyelitis by chemokines and chemokine receptors Immunol Res 25 2002 167 175
14. J.M. Fletcher, R. Lonergan, L. Costelloe, K. Kinsella, B. Moran, and C. O'Farrelly CD39+Foxp3 + regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis J Immunol 183 2009 7602 7610
15. R. Gold, C. Linington, and H. Lassmann Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research Brain 129 2006 1953 1971
16. A. Hakansson, and G. Molin Gut microbiota and inflammation Nutrients 3 2011 637 682
17. R. Har-el, and M.L. Tanzer Extracellular matrix. 3: evolution of the extracellular matrix in invertebrates FASEB J 7 1993 1115 1123
18. L.E. Harrington, R.D. Hatton, P.R. Mangan, H. Turner, T.L. Murphy, and K.M. Murphy Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages Nat Immunol 6 2005 1123 1132
19. M. Hook, L. Kjellen, and S. Johansson Cell-surface glycosaminoglycans Annu Rev Biochem 53 1984 847 869
20. C. Infante-Duarte, H.F. Horton, M.C. Byrne, and T. Kamradt Microbial lipopeptides induce the production of IL-17 in Th cells J Immunol 165 2000 6107 6115
21. I.I. Ivanov, B.S. McKenzie, L. Zhou, C.E. Tadokoro, A. Lepelley, and J.J. Lafaille The orphan nuclear receptor RORgt directs the differentiation program of proinflammatory IL-17 + T helper cells Cell 126 2006 1121 1133
22. I.I. Ivanov, L. Zhou, and D.R. Littman Transcriptional regulation of Th17 cell differentiation Semin Immunol 19 2007 409 417
23. C.L. Langrish, Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, and J.D. Sedgwick IL-23 drives a pathogenic T cell population that induces autoimmune inflammation J Exp Med 201 2005 233 240
24. O. Lider, E. Baharav, Y.A. Mekori, T. Miller, Y. Naparstek, and I. Vlodavsky Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins J Clin Invest 83 1989 752 756
25. O. Lider, Y.A. Mekori, T. Miller, R. Bar-Tana, I. Vlodavsky, and E. Baharav Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity Eur J Immunol 20 1990 493 499
26. M. Majima, K. Takagaki, S. Sudo, S. Yoshihara, Y. Kudo, and S. Yamagishi Effect of proteoglycan on experimental colitis M. Endo, S. Harata, Y. Saito, A. Munakata, M. Sasaki, S. Tsuchida, New developments in glycomedicine 2001 Elsevier Science BV Amsterdam, the Netherlands 221 224
27. B.S. McKenzie, R.A. Kastelein, and D.J. Cua Understanding the IL-23-IL-17 immune pathway Trends Immunol 27 2006 17 23
28. T. Owens, H. Wekerle, and J. Antel Genetic models for CNS inflammation Nat Med 7 2001 161 166
29. H.S. Panitch, R.L. Hirsch, J. Schindler, and K.P. Johnson Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system Neurology 37 1987 1097 1102
30. H. Park, Z. Li, X.O. Yang, S.H. Chang, R. Nurieva, and Y.H. Wang A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 Nat Immunol 6 2005 1133 1141
31. M. Prinz, H. Schmidt, A. Mildner, K.P. Knobeloch, U.K. Hanisch, and J. Raasch Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system Immunity 28 2008 675 686
32. N.M. Rebenko-Moll, L. Liu, A. Cardona, and R.M. Ransohoff Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details Curr Opin Immunol 18 2006 683 689
33. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J Immunol 155 1995 1151 1164
34. S. Sakaguchi, R. Setoguchi, H. Yagi, and T. Nomura Naturally arising Foxp3-expressing CD25+CD4 + regulatory T cells in self-tolerance and autoimmune disease Curr Top Microbiol Immunol 305 2006 51 66
35. H. Sashinami, A. Nakane, Y. Iwakura, and M. Sasaki Effective induction of acquired resistance to Listeria monocytogenes by immunizing mice with in vivo-infected dendritic cells Infect Immun 71 2003 117 125
36. H. Sashinami, K. Takagaki, and A. Nakane Salmon cartilage proteoglycan modulates cytokine responses to Escherichia coli in mouse macrophages Biochem Biophys Res Commun 351 2006 1005 1010
37. E.M. Shevach Mechanisms of Foxp3 + T regulatory cell-mediated suppression Immunity 30 2009 636 645
38. I. Sonderegger, J. Kisielow, R. Meier, C. King, and M. Kopf IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo Eur J Immunol 38 2008 1833 1838
39. L. Steinman Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system Cell 85 1996 299 302
40. V.B. Young The intestinal microbiota in health and disease Curr Opin Gastroenterol 28 2012 63 69